FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway
Authors:
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 398 (1) , 112401
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81760460)
This publication has 24 references indexed in Scilit:
- The Role of Surgery in Metastatic Bladder Cancer: A Systematic ReviewEuropean Urology, 2018
- Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic ReviewBladder Cancer, 2018
- Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor SuppressorClinical Cancer Research, 2017
- Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivinOncotarget, 2016
- The Ubiquitin-like Protein FAT10 Stabilizes eEF1A1 Expression to Promote Tumor Proliferation in a Complex MannerCancer Research, 2016
- Insights into B-type RR members as signaling partners acting downstream of HPt partners of HK1 in the osmotic stress response in PopulusPlant Physiology and Biochemistry, 2015
- Disruption of FAT10–MAD2 binding inhibits tumor progressionProceedings of the National Academy of Sciences, 2014
- Ubiquitin-like Protein FAT10 Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Modifying β-Catenin DegradationCancer Research, 2014
- Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer GrowthCell Reports, 2014
- The Ubiquitin-Like Protein FAT10 Mediates NF-κB ActivationJournal of the American Society of Nephrology, 2010